108.7K XNAS Volume
XNAS 18 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| David Angulo | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 262,927 | 770,798 (0%) | 0% | 0 | Common Stock | |
| David Angulo | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 394,391 | 394,391 | - | - | Employee Stock Option (Right to Buy) | |
| Scott Sukenick | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 92,511 | 436,706 (0%) | 0% | 0 | Common Stock | |
| Scott Sukenick | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 138,767 | 138,767 | - | - | Employee Stock Option (Right to Buy) | |
| Ivor Macleod | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 92,511 | 260,696 (0%) | 0% | 0 | Common Stock | |
| Ivor Macleod | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 138,767 | 138,767 | - | - | Employee Stock Option (Right to Buy) | |
| David Angulo | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.37 per share. | 12 Sep 2024 | 20,000 | 507,871 (0%) | 0% | 1.4 | 27,400 | Common Stock |
| David C. Hastings | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 23,000 | 23,000 | - | - | Stock Option | |
| David C. Hastings | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 23,000 | 46,183 (0%) | 0% | 0 | Common Stock | |
| Guy Macdonald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 23,000 | 23,000 | - | - | Stock Option | |
| Guy Macdonald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 23,000 | 55,000 (0%) | 0% | 0 | Common Stock | |
| Steven C. Gilman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 23,000 | 47,000 (0%) | 0% | 0 | Common Stock | |
| Steven C. Gilman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 23,000 | 23,000 | - | - | Stock Option | |
| Armando Anido | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 23,000 | 23,000 | - | - | Stock Option | |
| Armando Anido | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 23,000 | 48,000 (0%) | 0% | 0 | Common Stock | |
| Ann F. Hanham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 23,000 | 46,622 (0%) | 0% | 0 | Common Stock | |
| Ann F. Hanham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 23,000 | 23,000 | - | - | Stock Option | |
| Brian Philippe Tinmouth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 23,000 | 51,000 (0%) | 0% | 0 | Common Stock | |
| Brian Philippe Tinmouth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 23,000 | 23,000 | - | - | Stock Option | |
| Scott Sukenick | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.63 per share. | 16 Feb 2024 | 15,179 | 336,195 (0%) | 0% | 1.6 | 24,742 | Common Stock |
| Ivor Macleod | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2024 | 143,675 | 160,185 (0%) | 0% | 0 | Common Stock | |
| Ivor Macleod | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2024 | 215,515 | 215,515 | - | - | Employee Stock Option (Right to Buy) | |
| David Angulo | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2024 | 290,590 | 479,871 (0%) | 0% | 0 | Common Stock | |
| David Angulo | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2024 | 431,030 | 431,030 | - | - | Employee Stock Option (Right to Buy) | |
| Sukenick Scott | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2024 | 215,515 | 215,515 | - | - | Employee Stock Option (Right to Buy) | |
| Sukenick Scott | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2024 | 143,675 | 351,374 (0%) | 0% | 0 | Common Stock | |
| David C. Hastings | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 10,000 | 23,183 (0%) | 0% | 0 | Common Stock | |
| David C. Hastings | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 10,000 | 10,000 | - | - | Stock Option | |
| Guy Macdonald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 10,000 | 10,000 | - | - | Stock Option | |
| Steven C. Gilman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 10,000 | 10,000 | - | - | Stock Option | |
| Armando Anido | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 10,000 | 25,000 (0%) | 0% | 0 | Common Stock | |
| Armando Anido | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 10,000 | 10,000 | - | - | Stock Option | |
| Ann F. Hanham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 10,000 | 10,000 | - | - | Stock Option | |
| Ann F. Hanham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 10,000 | 23,622 (0%) | 0% | 0 | Common Stock | |
| Brian Philippe Tinmouth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 10,000 | 10,000 | - | - | Stock Option | |
| Scott Sukenick | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 50,000 | 203,599 (0%) | 0% | 0 | Common Stock | |
| Scott Sukenick | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2023 | 100,000 | 153,599 (0%) | 0% | 0 | Common Stock | |
| David Angulo | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2023 | 165,000 | 165,000 | - | - | Employee Stock Option (Right to Buy) | |
| David Angulo | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2023 | 110,000 | 185,181 (0%) | 0% | 0 | Common Stock | |
| Ivor Macleod | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2022 | 170,000 | 170,000 | - | - | Stock Option (Right to Buy) | |
| Ivor Macleod | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2022 | 15,000 | 15,000 (0%) | 0% | 0 | Common Stock | |
| David C. Hastings | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| David C. Hastings | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 10,000 | 13,183 (0%) | 0% | 0 | Common Stock | |
| Guy Macdonald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 10,000 | 22,000 (0%) | 0% | 0 | Common Stock | |
| Guy Macdonald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Steven C. Gilman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Steven C. Gilman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 10,000 | 14,000 (0%) | 0% | 0 | Common Stock | |
| Armando Anido | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Armando Anido | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 10,000 | 15,000 (0%) | 0% | 0 | Common Stock | |
| Ann F. Hanham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 10,000 | 13,622 (0%) | 0% | 0 | Common Stock | |
| Ann F. Hanham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Brian Philippe Tinmouth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Brian Philippe Tinmouth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 10,000 | 18,000 (0%) | 0% | 0 | Common Stock | |
| Marco Taglietti | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 3.00 per share. | 26 Apr 2022 | 75,000 | 272,068 (0%) | 0% | 3 | 225,000 | Common Stock |
| Marco Taglietti | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2022 | 75,000 | 75,000 | - | - | Common Stock Warrant | |
| Scott Sukenick | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2022 | 3,500 | 3,500 | - | - | Common Stock Warrant | |
| Scott Sukenick | General Counsel | Purchase of securities on an exchange or from another person at price $ 3.00 per share. | 26 Apr 2022 | 3,500 | 53,499 (0%) | 0% | 3 | 10,500 | Common Stock |
| Marco Taglietti | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 87,200 | 196,968 (0%) | 0% | 0 | Common Stock | |
| Marco Taglietti | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 232,000 | 232,000 | - | - | Stock Option (Right to Buy) | |
| David Angulo | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 85,000 | 85,000 | - | - | Stock Option (Right to Buy) | |
| David Angulo | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 51,100 | 74,981 (0%) | 0% | 0 | Common Stock | |
| Scott Sukenick | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 40,700 | 49,899 (0%) | 0% | 0 | Common Stock | |
| Scott Sukenick | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 70,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
| Christine Coyne | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 43,200 | 58,200 (0%) | 0% | 0 | Common Stock | |
| Christine Coyne | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| David C. Hastings | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Guy Macdonald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Steven C. Gilman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Armando Anido | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Ann F. Hanham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Brian Philippe Tinmouth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Christine Coyne | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2021 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
| Christine Coyne | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2021 | 15,000 | 15,000 (0%) | 0% | 0 | Common Stock | |
| Marco Taglietti | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2021 | 170,000 | 170,000 | - | - | Stock Option (Right to Buy) | |
| Eric Francois | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2021 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| David Angulo | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2021 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Scott Sukenick | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2021 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Guy Macdonald | Director | Purchase of securities on an exchange or from another person at price $ 6.25 per share. | 21 Dec 2020 | 8,000 | 12,000 (0%) | 0% | 6.3 | 50,000 | Common Stock |
| Guy Macdonald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2020 | 4,000 | 4,000 | - | - | Common Stock Warrant | |
| Guy Macdonald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2020 | 4,000 | 4,000 | - | - | Common Stock Warrant | |
| Steven C. Gilman | Director | Purchase of securities on an exchange or from another person at price $ 6.25 per share. | 21 Dec 2020 | 4,000 | 4,000 (0%) | 0% | 6.3 | 25,000 | Common Stock |
| Steven C. Gilman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2020 | 2,000 | 2,000 | - | - | Common Stock Warrant | |
| Steven C. Gilman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2020 | 2,000 | 2,000 | - | - | Common Stock Warrant | |
| Armando Anido | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2020 | 2,500 | 2,500 | - | - | Common Stock Warrant | |
| Armando Anido | Director | Purchase of securities on an exchange or from another person at price $ 6.25 per share. | 21 Dec 2020 | 5,000 | 5,000 (0%) | 0% | 6.3 | 31,250 | Common Stock |
| Armando Anido | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2020 | 2,500 | 2,500 | - | - | Common Stock Warrant | |
| Marco Taglietti | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2020 | 20,000 | 20,000 | - | - | Common Stock Warrant | |
| Marco Taglietti | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 6.25 per share. | 21 Dec 2020 | 40,000 | 109,668 (0%) | 0% | 6.3 | 250,000 | Common Stock |
| Marco Taglietti | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2020 | 20,000 | 20,000 | - | - | Common Stock Warrant | |
| Ann F. Hanham | Director | Purchase of securities on an exchange or from another person at price $ 6.25 per share. | 21 Dec 2020 | 3,200 | 3,622 (0%) | 0% | 6.3 | 20,000 | Common Stock |
| Ann F. Hanham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2020 | 1,600 | 1,600 | - | - | Common Stock Warrant | |
| Ann F. Hanham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2020 | 1,600 | 1,600 | - | - | Common Stock Warrant | |
| Eric Francois | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 6.25 per share. | 21 Dec 2020 | 600 | 11,732 (0%) | 0% | 6.3 | 3,750 | Common Stock |
| Eric Francois | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2020 | 300 | 300 | - | - | Common Stock Warrant | |
| Eric Francois | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2020 | 300 | 300 | - | - | Common Stock Warrant | |
| David Angulo | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 6.25 per share. | 21 Dec 2020 | 1,600 | 23,780 (0%) | 0% | 6.3 | 10,000 | Common Stock |
| David Angulo | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2020 | 800 | 800 | - | - | Common Stock Warrant | |
| David Angulo | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2020 | 800 | 800 | - | - | Common Stock Warrant | |
| Scott Sukenick | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2020 | 800 | 800 | - | - | Common Stock Warrant | |
| Scott Sukenick | General Counsel | Purchase of securities on an exchange or from another person at price $ 6.25 per share. | 21 Dec 2020 | 1,600 | 9,099 (0%) | 0% | 6.3 | 10,000 | Common Stock |
| Scott Sukenick | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2020 | 800 | 800 | - | - | Common Stock Warrant | |
| Philippe Tinmouth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2020 | 4,000 | 4,000 | - | - | Common Stock Warrant | |
| Philippe Tinmouth | Director | Purchase of securities on an exchange or from another person at price $ 6.25 per share. | 21 Dec 2020 | 8,000 | 8,000 (0%) | 0% | 6.3 | 50,000 | Common Stock |
| Philippe Tinmouth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2020 | 4,000 | 4,000 | - | - | Common Stock Warrant | |
| David C. Hastings | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jul 2020 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| Guy Macdonald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jul 2020 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| Steven C. Gilman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jul 2020 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| Armando Anido | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jul 2020 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| Ann F. Hanham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jul 2020 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| Philippe Tinmouth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jul 2020 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| Eric Francois | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.81 per share. | 15 Feb 2020 | 3,480 | 11,132 (0%) | 0% | 6.8 | 23,699 | Common Stock |
| Eric Francois | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.80 per share. | 15 Feb 2020 | 979 | 14,412 (0%) | 0% | 9.8 | 9,594 | Common Stock |
| David Angulo | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.81 per share. | 15 Feb 2020 | 4,323 | 22,180 (0%) | 0% | 6.8 | 29,440 | Common Stock |
| David Angulo | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.80 per share. | 15 Feb 2020 | 1,175 | 26,303 (0%) | 0% | 9.8 | 11,515 | Common Stock |
| Scott Sukenick | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.80 per share. | 15 Feb 2020 | 783 | 9,912 (0%) | 0% | 9.8 | 7,673 | Common Stock |
| Scott Sukenick | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.81 per share. | 15 Feb 2020 | 2,613 | 7,499 (0%) | 0% | 6.8 | 17,795 | Common Stock |
| Marco Taglietti | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2020 | 900,000 | 900,000 | - | - | Stock Option (Right to Buy) | |
| Eric Francois | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2020 | 375,000 | 375,000 | - | - | Stock Option (Right to Buy) | |
| David Angulo | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2020 | 450,000 | 450,000 | - | - | Stock Option (Right to Buy) | |
| Scott Sukenick | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2020 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | |
| Philippe Tinmouth | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2019 | 70,000 | 70,000 | - | - | Stock Option (right to buy) | |
| Marco Taglietti | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.90 per share. | 12 Dec 2019 | 166,667 | 693,682 (0%) | 0% | 0.9 | 150,000 | Common Stock |
| Marco Taglietti | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 12 Dec 2019 | 166,667 | 166,667 | - | - | Common Stock Warrant (right to buy) | |
| Marco Taglietti | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.11 per share. | 20 Aug 2019 | 9,500 | 526,015 (0%) | 0% | 1.1 | 10,545 | Common Stock |
| Marco Taglietti | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.11 per share. | 20 Aug 2019 | 500 | 516,515 (0%) | 0% | 1.1 | 555 | Common Stock |
| Marco Taglietti | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.01 per share. | 15 Aug 2019 | 10,015 | 516,015 (0%) | 0% | 1.0 | 10,115 | Common Stock |
| David C. Hastings | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2019 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| Guy Macdonald | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2019 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| Steven C. Gilman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2019 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| Armando Anido | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2019 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| Ann F. Hanham | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2019 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| Marco Taglietti | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.63 per share. | 17 Apr 2019 | 25,000 | 506,000 (0%) | 0% | 1.6 | 40,750 | Common Stock |
| Marco Taglietti | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2019 | 700,000 | 700,000 | - | - | Stock Option (Right to Buy) | |
| Eric Francois | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2019 | 125,000 | 149,917 (0%) | 0% | 0 | Common Stock | |
| Eric Francois | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2019 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
| David Angulo | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2019 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| David Angulo | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2019 | 150,000 | 271,790 (0%) | 0% | 0 | Common Stock | |
| Scott Sukenick | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2019 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Scott Sukenick | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2019 | 100,000 | 102,959 (0%) | 0% | 0 | Common Stock | |
| Armando Anido | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2019 | 70,000 | 70,000 | - | - | Stock Option (right to buy) | |
| Marco Taglietti | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.69 per share. | 10 Jan 2019 | 25,000 | 480,000 (0%) | 0% | 0.7 | 17,250 | Common Stock |
| Patrick C. Machado | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2019 | 22,500 | 22,500 | - | - | Stock Option (right to buy) | |
| David C. Hastings | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2019 | 22,500 | 22,500 | - | - | Stock Option (right to buy) | |
| Guy Macdonald | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2019 | 22,500 | 22,500 | - | - | Stock Option (right to buy) | |
| Steven C. Gilman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2019 | 22,500 | 22,500 | - | - | Stock Option (right to buy) | |
| Ann F. Hanham | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2019 | 22,500 | 22,500 | - | - | Stock Option (right to buy) | |
| Marco Taglietti | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.46 per share. | 31 Dec 2018 | 25,000 | 455,000 (0%) | 0% | 0.5 | 11,500 | Common stock |
| David Angulo | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.50 per share. | 31 Dec 2018 | 12,000 | 121,790 (0%) | 0% | 0.5 | 5,951 | Common stock |
| Guy Macdonald | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2018 | 21,595 | 21,595 | - | - | Stock option (right to buy) | |
| David Gonzalez Angulo | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.27 per share. | 06 Sep 2018 | 7,000 | 108,790 (0%) | 0% | 1.3 | 8,890 | Common Stock |
| Marco Taglietti | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.29 per share. | 23 Aug 2018 | 25,000 | 429,000 (0%) | 0% | 1.3 | 32,250 | Common Stock |
| Guy Macdonald | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2018 | 15,589 | 15,589 | - | - | Stock option (right to buy) | |
| Marion McCourt | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2018 | 9,217 | 9,217 | - | - | Stock option (right to buy) | |
| Guy Macdonald | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2018 | 19,959 | 19,959 | - | - | Stock option (right to buy) | |
| Marion McCourt | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2018 | 11,800 | 11,800 | - | - | Stock option (right to buy) | |
| David Gonzalez Angulo | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.36 per share. | 29 Mar 2018 | 6,000 | 101,790 (0%) | 0% | 1.4 | 8,160 | Common Stock |
| David C. Hastings | None | Purchase of securities on an exchange or from another person at price $ 1.69 per share. | 08 Mar 2018 | 11,834 | 31,834 (0%) | 0% | 1.7 | 19,999 | Common Stock |
| David C. Hastings | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 08 Mar 2018 | 8,875 | 8,875 | - | - | Common Stock Warrant (right to buy) | |
| David C. Hastings | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 08 Mar 2018 | 5,325 | 5,325 | - | - | Common Stock Warrant (right to buy) | |
| Marco Taglietti | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 08 Mar 2018 | 75,000 | 75,000 | - | - | Common Stock Warrant (right to buy) | |
| Marco Taglietti | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.69 per share. | 08 Mar 2018 | 100,000 | 404,000 (0%) | 0% | 1.7 | 169,000 | Common Stock |
| Marco Taglietti | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 08 Mar 2018 | 45,000 | 45,000 | - | - | Common Stock Warrant (right to buy) | |
| David Gonzalez Angulo | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.69 per share. | 08 Mar 2018 | 14,790 | 88,790 (0%) | 0% | 1.7 | 24,995 | Common Stock |
| David Gonzalez Angulo | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 08 Mar 2018 | 11,092 | 11,092 | - | - | Common Stock Warrant (right to buy) | |
| David Gonzalez Angulo | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 08 Mar 2018 | 6,655 | 6,655 | - | - | Common Stock Warrant (right to buy) | |
| David Gonzalez Angulo | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.39 per share. | 08 Mar 2018 | 7,000 | 95,790 (0%) | 0% | 1.4 | 9,730 | Common Stock |
| Eric Francois | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 08 Mar 2018 | 4,437 | 4,437 | - | - | Common Stock Warrant (right to buy) | |
| Eric Francois | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 08 Mar 2018 | 2,662 | 2,662 | - | - | Common Stock Warrant (right to buy) | |
| Eric Francois | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.69 per share. | 08 Mar 2018 | 5,917 | 24,917 (0%) | 0% | 1.7 | 10,000 | Common Stock |
| Scott Sukenick | General Counsel | Purchase of securities on an exchange or from another person at price $ 1.69 per share. | 08 Mar 2018 | 2,959 | 2,959 (0%) | 0% | 1.7 | 5,001 | Common Stock |
| Scott Sukenick | General Counsel | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 08 Mar 2018 | 1,331 | 1,331 | - | - | Common Stock Warrant (right to buy) | |
| Scott Sukenick | General Counsel | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 08 Mar 2018 | 2,219 | 2,219 | - | - | Common Stock Warrant (right to buy) | |
| Marco Taglietti | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2018 | 375,000 | 375,000 | - | - | Stock option (right to buy) | |
| David Gonzalez Angulo | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2018 | 200,000 | 200,000 | - | - | Stock option (right to buy) | |
| Eric Francois | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2018 | 150,000 | 150,000 | - | - | Stock option (right to buy) | |
| Scott Sukenick | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2018 | 15,000 | 15,000 | - | - | Stock option (right to buy) | |
| Patrick C. Machado | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2018 | 19,989 | 19,989 | - | - | Stock Option (right to buy) | |
| David C. Hastings | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2018 | 19,989 | 19,989 | - | - | Stock Option (right to buy) | |
| Guy Macdonald | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2018 | 11,555 | 11,555 | - | - | Stock Option (right to buy) | |
| Guy Macdonald | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2018 | 19,989 | 19,989 | - | - | Stock Option (right to buy) | |
| Steven C. Gilman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2018 | 19,989 | 19,989 | - | - | Stock Option (right to buy) | |
| Ann F. Hanham | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2018 | 19,989 | 19,989 | - | - | Stock Option (right to buy) | |
| Marion McCourt | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2018 | 6,831 | 6,831 | - | - | Stock Option (right to buy) | |
| Marion McCourt | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2018 | 19,989 | 19,989 | - | - | Stock Option (right to buy) | |
| Scott Sukenick | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2017 | 160,000 | 160,000 | - | - | Stock Option (right to buy) | |
| Guy Macdonald | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2017 | 10,709 | 10,709 | - | - | Stock Option (right to buy) | |
| Steven C. Gilman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2017 | 1,807 | 1,807 | - | - | Stock Option (right to buy) | |
| Marion McCourt | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2017 | 6,332 | 6,332 | - | - | Stock Option (right to buy) | |
| Marco Taglietti | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.23 per share. | 22 Sep 2017 | 10,000 | 303,000 (1%) | 0% | 2.2 | 22,300 | Common Stock |
| Marco Taglietti | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.57 per share. | 22 Aug 2017 | 7 | 287,007 (1%) | 0% | 1.6 | 11 | Common Stock |
| Marco Taglietti | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.85 per share. | 22 Aug 2017 | 4,993 | 292,000 (1%) | 0% | 1.8 | 9,237 | Common Stock |
| Marco Taglietti | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.61 per share. | 15 Aug 2017 | 10,000 | 287,000 (1%) | 0% | 1.6 | 16,100 | Common Stock |
| David Gonzalez Angulo | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.55 per share. | 11 Aug 2017 | 10,000 | 72,000 (0%) | 0% | 1.6 | 15,500 | Common Stock |
| Guy Macdonald | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2017 | 14,396 | 14,396 | - | - | Stock Option (right to buy) | |
| Steven C. Gilman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2017 | 2,430 | 2,430 | - | - | Stock Option (right to buy) | |
| Marion McCourt | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2017 | 8,511 | 8,511 | - | - | Stock Option (right to buy) | |
| David C. Hastings | None | Purchase of securities on an exchange or from another person at price $ 1.75 per share. | 21 Jun 2017 | 20,000 | 20,000 (0%) | 0% | 1.8 | 35,000 | Common Stock |
| Marco Taglietti | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.69 per share. | 12 May 2017 | 25,000 | 277,000 (1%) | 0% | 1.7 | 42,250 | Common Stock |
| David Gonzalez Angulo | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.70 per share. | 12 May 2017 | 15,000 | 62,000 (0%) | 0% | 1.7 | 25,500 | Common Stock |
| Guy Macdonald | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2017 | 9,941 | 9,941 | - | - | Stock Option (right to buy) | |
| Steven C. Gilman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2017 | 1,678 | 1,678 | - | - | Stock Option (right to buy) | |
| Marion McCourt | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2017 | 5,878 | 5,878 | - | - | Stock Option (right to buy) | |
| Marco Taglietti | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2017 | 360,000 | 360,000 | - | - | Stock Option (right to buy) | |
| David Gonzalez Angulo | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2017 | 140,000 | 140,000 | - | - | Stock Option (right to buy) | |
| Marion McCourt | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2017 | 34,144 | 34,144 | - | - | Stock Option (right to buy) | |
| Marion McCourt | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2017 | 4,274 | 4,274 | - | - | Stock Option (right to buy) | |
| Patrick C. Machado | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2017 | 14,499 | 14,499 | - | - | Stock Option (right to buy) | |
| David C. Hastings | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2017 | 14,499 | 14,499 | - | - | Stock Option (right to buy) | |
| Guy Macdonald | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2017 | 14,499 | 14,499 | - | - | Stock Option (right to buy) | |
| Guy Macdonald | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2017 | 7,749 | 7,749 | - | - | Stock Option (right to buy) | |
| Steven C. Gilman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2017 | 1,308 | 1,308 | - | - | Stock Option (right to buy) | |
| Steven C. Gilman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2017 | 14,499 | 14,499 | - | - | Stock Option (right to buy) | |
| Ann F. Hanham | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2017 | 14,499 | 14,499 | - | - | Stock Option (right to buy) | |
| Patrick J. Langlois | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2017 | 14,499 | 14,499 | - | - | Stock Option (right to buy) | |
| Marco Taglietti | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 21 Dec 2016 | 25,000 | 251,000 | - | - | Common Stock | |
| David Gonzalez Angulo | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 16 Dec 2016 | 4,000 | 46,000 | - | - | Common Stock | |
| Guy Macdonald | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2016 | 6,255 | 6,255 | - | - | Stock Option (right to buy) | |
| Steven C. Gilman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2016 | 977 | 977 | - | - | Stock Option (right to buy) | |
| C. Patrick Machado | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 15 Sep 2016 | 40,000 | 60,000 | - | - | Common Stock | |
| Guy Macdonald | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2016 | 12,996 | 12,996 | - | - | Stock Option (right to buy) | |
| Steven C. Gilman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2016 | 2,030 | 2,030 | - | - | Stock Option (right to buy) | |
| David Gonzalez Angulo | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 29 Jun 2016 | 32,150 | 41,000 | - | - | Common Stock | |
| David Gonzalez Angulo | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 29 Jun 2016 | 4,800 | 8,850 | - | - | Common Stock | |
| C. Patrick Machado | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 24 Jun 2016 | 20,000 | 20,000 | - | - | Common Stock | |
| C. Patrick Machado | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 24 Jun 2016 | 9,000 | 9,000 | - | - | Common Stock Warrant (right to buy) | |
| Guy Macdonald | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 24 Jun 2016 | 18,000 | 18,000 | - | - | Common Stock Warrant (right to buy) | |
| Guy Macdonald | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 24 Jun 2016 | 40,000 | 40,000 | - | - | Common Stock | |
| Marco Taglietti | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 24 Jun 2016 | 45,000 | 45,000 | - | - | Common Stock Warrant (right to buy) | |
| Marco Taglietti | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 24 Jun 2016 | 100,000 | 225,000 | - | - | Common Stock | |
| Eric Francois | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 24 Jun 2016 | 15,000 | 15,000 | - | - | Common Stock | |
| Eric Francois | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 24 Jun 2016 | 6,750 | 6,750 | - | - | Common Stock Warrant (right to buy) | |
| David C. Hastings | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2016 | 8,800 | 8,800 | - | - | Stock Option (right to buy) | |
| Ann F. Hanham | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2016 | 8,800 | 8,800 | - | - | Stock Option (right to buy) | |
| C. Patrick Machado | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2016 | 8,800 | 8,800 | - | - | Stock Option (right to buy) | |
| Guy Macdonald | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2016 | 8,800 | 8,800 | - | - | Stock Option (right to buy) | |
| Patrick J. Langlois | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2016 | 8,800 | 8,800 | - | - | Stock Option (right to buy) | |
| Steven C. Gilman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2016 | 8,800 | 8,800 | - | - | Stock Option (right to buy) | |
| Ann F. Hanham | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 25 May 2016 | 4,225 | 4,225 | - | - | Common Stock | |
| Marco Taglietti | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 25 May 2016 | 5,754 | 124,754 | - | - | Common Stock | |
| Marco Taglietti | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 25 May 2016 | 246 | 125,000 | - | - | Common Stock | |
| Marco Taglietti | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 24 May 2016 | 5,500 | 119,000 | - | - | Common Stock | |
| Marco Taglietti | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 20 May 2016 | 3,000 | 113,500 | - | - | Common Stock | |
| Marco Taglietti | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 20 May 2016 | 4,500 | 110,500 | - | - | Common Stock | |
| Marco Taglietti | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 19 May 2016 | 6,000 | 106,000 | - | - | Common Stock | |
| Guy Macdonald | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2016 | 7,027 | 7,027 | - | - | Stock Option (right to buy) | |
| Steven C. Gilman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2016 | 1,098 | 1,098 | - | - | Stock Option (right to buy) | |
| Marco Taglietti | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2016 | 185,000 | 185,000 | - | - | Stock Option (right to buy) | |
| Eric Francois | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2016 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| David Angulo | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2016 | 70,000 | 70,000 | - | - | Stock Option (right to buy) | |
| Guy Macdonald | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2016 | 4,666 | 4,666 | - | - | Stock Option (right to buy) | |
| Steven C. Gilman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2016 | 729 | 729 | - | - | Stock Option (right to buy) | |
| Marco Taglietti | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 23 Nov 2015 | 15,000 | 92,267 | - | - | Common Stock | |
| Marco Taglietti | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 23 Nov 2015 | 7,733 | 100,000 | - | - | Common Stock | |
| Eric Francois | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2015 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Guy Macdonald | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2015 | 4,286 | 4,286 | - | - | Stock Option (right to buy) | |
| Patrick Langlois | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2015 | 1,607 | 1,607 | - | - | Stock Option (right to buy) | |
| Steven C. Gilman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2015 | 670 | 670 | - | - | Stock Option (right to buy) | |
| David C. Hastings | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2015 | 11,700 | 11,700 | - | - | Stock Option (right to buy) | |
| C. Patrick Machado | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2015 | 11,700 | 11,700 | - | - | Stock Option (right to buy) | |
| David Gonzalez Angulo | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 15 Sep 2015 | 3,000 | 3,000 | - | - | Common Stock | |
| Marco Taglietti | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Aug 2015 | 25,000 | 77,267 | - | - | Common Stock | |
| Marco Taglietti | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 27 Aug 2015 | 1,867 | 51,867 | - | - | Common Stock | |
| Marco Taglietti | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 27 Aug 2015 | 400 | 52,267 | - | - | Common Stock | |
| Marco Taglietti | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 25 Aug 2015 | 5,000 | 5,000 | - | - | Common Stock | |
| Marco Taglietti | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 25 Aug 2015 | 20,000 | 25,000 | - | - | Common Stock | |
| Marco Taglietti | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 25 Aug 2015 | 25,000 | 50,000 | - | - | Common Stock | |
| Yves J. Ribeill | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2015 | 8,800 | 8,800 | - | - | Stock Option (right to buy) | |
| Guy Macdonald | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2015 | 2,974 | 2,974 | - | - | Stock Option (right to buy) | |
| Patrick Langlois | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2015 | 1,465 | 1,465 | - | - | Stock Option (right to buy) | |
| Steven C. Gilman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2015 | 502 | 502 | - | - | Stock Option (right to buy) | |
| Edward E. Penhoet | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2015 | 8,800 | 8,800 | - | - | Stock Option (right to buy) | |
| Ann F. Hanham | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2015 | 8,800 | 8,800 | - | - | Stock Option (right to buy) | |
| Guy Macdonald | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2015 | 8,800 | 8,800 | - | - | Stock Option (right to buy) | |
| Patrick Langlois | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2015 | 8,800 | 8,800 | - | - | Stock Option (right to buy) | |
| Steven C. Gilman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2015 | 8,800 | 8,800 | - | - | Stock Option (right to buy) | |
| David Gonzalez Angulo | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2015 | 125,000 | 125,000 | - | - | Stock Option (right to buy) | |
| Pamela J Kirby | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2015 | 1,976 | 1,976 | - | - | Stock Option (right to buy) | |
| Guy Macdonald | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2015 | 1,976 | 1,976 | - | - | Stock Option (right to buy) | |
| Patrick Langlois | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2015 | 1,207 | 1,207 | - | - | Stock Option (right to buy) | |
| Steven C. Gilman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2015 | 554 | 544 | - | - | Stock Option (right to buy) | |
| Marco Taglietti | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2015 | 330,000 | 330,000 | - | - | Stock Option (right to buy) | |
| Yves J. Ribeill | Director, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2015 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Charles F. Osborne | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2015 | 9,541 | 9,541 | - | - | Stock Option (right to buy) | |
| Jean-Yves Nothias | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2015 | 1,690 | 1,690 | - | - | Stock Option (right to buy) | |
| Steven C. Gilman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2015 | 7,830 | 7,830 | - | - | Stock Option (right to buy) | |
| Steven C. Gilman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2015 | 486 | 486 | - | - | Stock Option (right to buy) | |
| Ann F. Hanham | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2015 | 2,047 | 2,047 | - | - | Stock Option (right to buy) | |
| Pamela J Kirby | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2015 | 1,738 | 1,738 | - | - | Stock Option (right to buy) | |
| Guy Macdonald | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2015 | 1,738 | 1,738 | - | - | Stock Option (right to buy) | |
| Patrick Langlois | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2015 | 869 | 869 | - | - | Stock Option (right to buy) | |
| Marco Taglietti | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2015 | 1,660 | 1,660 | - | - | Stock Option (right to buy) | |
| Jean-Yves Nothias | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2015 | 1,274 | 1,274 | - | - | Stock Option (right to buy) | |
| Guy Macdonald | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2014 | 7,830 | 7,830 | - | - | Stock Option (right to buy) | |
| Marco Taglietti | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2014 | 1,530 | 1,530 | - | - | Stock Option (right to buy) | |
| Marco Taglietti | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2014 | 7,830 | 7,830 | - | - | Stock Option (right to buy) | |
| Ann F. Hanham | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2014 | 2,048 | 2,048 | - | - | Stock Option (right to buy) | |
| Pamela J Kirby | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2014 | 2,248 | 2,248 | - | - | Stock Option (right to buy) | |
| Jean-Yves Nothias | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2014 | 1,648 | 1,648 | - | - | Stock Option (right to buy) | |
| Ann F. Hanham | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2014 | 1,964 | 1,964 | - | - | Stock Option (right to buy) | |
| Pamela J Kirby | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2014 | 2,155 | 2,155 | - | - | Stock Option (right to buy) | |
| Jean-Yves Nothias | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2014 | 1,581 | 1,581 | - | - | Stock Option (right to buy) | |
| Eileen C. Pruette | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2014 | 9,803 | 9,803 | - | - | Stock Option (right to buy) | |
| Eileen C. Pruette | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2014 | 25,230 | 25,230 | - | - | Stock Option (right to buy) | |
| Eileen C. Pruette | General Counsel | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Jun 2014 | 9,803 | 0 | - | - | Stock Option (right to buy) | |
| Yves J. Ribeill | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2014 | 1,960 | 1,960 | - | - | Stock Option (right to buy) | |
| Yves J. Ribeill | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2014 | 7,352 | 7,352 | - | - | Stock Option (right to buy) | |
| Yves J. Ribeill | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Jun 2014 | 1,960 | 0 | - | - | Stock Option (right to buy) | |
| Yves J. Ribeill | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Jun 2014 | 2,941 | 0 | - | - | Stock Option (right to buy) | |
| Yves J. Ribeill | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Jun 2014 | 2,941 | 0 | - | - | Stock Option (right to buy) | |
| Yves J. Ribeill | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2014 | 2,941 | 2,941 | - | - | Stock Option (right to buy) | |
| Yves J. Ribeill | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2014 | 7,352 | 7,352 | - | - | Stock Option (right to buy) | |
| Yves J. Ribeill | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2014 | 187,052 | 187,052 | - | - | Stock Option (right to buy) | |
| Yves J. Ribeill | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Jun 2014 | 7,352 | 0 | - | - | Stock Option (right to buy) | |
| Yves J. Ribeill | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2014 | 3,676 | 3,676 | - | - | Stock Option (right to buy) | |
| Yves J. Ribeill | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Jun 2014 | 3,676 | 0 | - | - | Stock Option (right to buy) | |
| Yves J. Ribeill | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Jun 2014 | 3,676 | 0 | - | - | Stock Option (right to buy) | |
| Yves J. Ribeill | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2014 | 931 | 931 | - | - | Stock Option (right to buy) | |
| Yves J. Ribeill | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2014 | 2,941 | 2,941 | - | - | Stock Option (right to buy) | |
| Yves J. Ribeill | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Jun 2014 | 7,352 | 0 | - | - | Stock Option (right to buy) | |
| Yves J. Ribeill | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Jun 2014 | 931 | 0 | - | - | Stock Option (right to buy) | |
| Yves J. Ribeill | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2014 | 3,676 | 3,676 | - | - | Stock Option (right to buy) | |
| Carole Sable | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2014 | 26,970 | 26,970 | - | - | Stock Option (right to buy) | |
| Carole Sable | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2014 | 46,636 | 46,636 | - | - | Stock Option (right to buy) | |
| Carole Sable | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Jun 2014 | 46,636 | 0 | - | - | Stock Option (right to buy) | |
| Charles F. Osborne | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2014 | 833 | 833 | - | - | Stock Option (right to buy) | |
| Charles F. Osborne | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2014 | 1,225 | 1,225 | - | - | Stock Option (right to buy) | |
| Charles F. Osborne | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Jun 2014 | 490 | 0 | - | - | Stock Option (right to buy) | |
| Charles F. Osborne | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Jun 2014 | 1,225 | 0 | - | - | Stock Option (right to buy) | |
| Charles F. Osborne | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Jun 2014 | 1,470 | 0 | - | - | Stock Option (right to buy) | |
| Charles F. Osborne | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2014 | 1,470 | 1,470 | - | - | Stock Option (right to buy) | |
| Charles F. Osborne | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2014 | 808 | 808 | - | - | Stock Option (right to buy) | |
| Charles F. Osborne | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Jun 2014 | 808 | 0 | - | - | Stock Option (right to buy) | |
| Charles F. Osborne | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Jun 2014 | 833 | 0 | - | - | Stock Option (right to buy) | |
| Charles F. Osborne | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2014 | 490 | 490 | - | - | Stock Option (right to buy) | |
| Charles F. Osborne | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2014 | 934 | 934 | - | - | Stock Option (right to buy) | |
| Charles F. Osborne | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Jun 2014 | 960 | 0 | - | - | Stock Option (right to buy) | |
| Charles F. Osborne | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2014 | 960 | 960 | - | - | Stock Option (right to buy) | |
| Charles F. Osborne | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2014 | 57,420 | 57,420 | - | - | Stock Option (right to buy) | |
| Charles F. Osborne | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Jun 2014 | 1,225 | 0 | - | - | Stock Option (right to buy) | |
| Charles F. Osborne | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Jun 2014 | 934 | 0 | - | - | Stock Option (right to buy) | |
| Charles F. Osborne | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2014 | 1,225 | 1,225 | - | - | Stock Option (right to buy) | |
| Edward E. Penhoet | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2014 | 3,480 | 3,480 | - | - | Stock Option (right to buy) | |
| Ann F. Hanham | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2014 | 3,480 | 3,480 | - | - | Stock Option (right to buy) | |
| Ann F. Hanham | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2014 | 1,204 | 1,204 | - | - | Stock Option (right to buy) | |
| Pamela J Kirby | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2014 | 5,220 | 5,220 | - | - | Stock Option (right to buy) | |
| Pamela J Kirby | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2014 | 1,321 | 1,321 | - | - | Stock Option (right to buy) | |
| Patrick Langlois | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2014 | 3,480 | 3,480 | - | - | Stock Option (right to buy) | |
| Laurent Arthaud | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2014 | 3,480 | 3,480 | - | - | Stock Option (right to buy) | |
| Mounia Chaoui | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2014 | 3,480 | 3,480 | - | - | Stock Option (right to buy) | |
| Jean-Yves Nothias | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2014 | 3,480 | 3,480 | - | - | Stock Option (right to buy) | |
| Jean-Yves Nothias | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2014 | 969 | 969 | - | - | Stock Option (right to buy) | |
| Farah Champsi | Ten Percent Owner | 07 May 2014 | 161,238 | 252,794 | - | - | Common Stock | ||
| Farah Champsi | Ten Percent Owner | 07 May 2014 | 570,159 | 0 | - | - | Series C Preferred Stock | ||
| Farah Champsi | Ten Percent Owner | 07 May 2014 | 174 | 174 | - | - | Common Stock | ||
| Farah Champsi | Ten Percent Owner | 07 May 2014 | 37,702 | 0 | - | - | Series D-1 Preferred Stock | ||
| Farah Champsi | Ten Percent Owner | 07 May 2014 | 4,551 | 0 | - | - | Common Stock Warrant (right to buy) | ||
| Farah Champsi | Ten Percent Owner | 07 May 2014 | 50,239 | 303,033 | - | - | Common Stock | ||
| Farah Champsi | Ten Percent Owner | 07 May 2014 | 82,454 | 91,556 | - | - | Common Stock | ||
| Farah Champsi | Ten Percent Owner | 07 May 2014 | 4,551 | 9,102 | - | - | Common Stock | ||
| Farah Champsi | Ten Percent Owner | 07 May 2014 | 4,551 | 0 | - | - | Common Stock Warrant (right to buy) | ||
| Farah Champsi | Ten Percent Owner | 07 May 2014 | 69,476 | 372,509 | - | - | Common Stock | ||
| Farah Champsi | Ten Percent Owner | 07 May 2014 | 82,454 | 0 | - | - | Common Stock Warrant (right to buy) | ||
| Farah Champsi | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 07 May 2014 | 868,066 | 1,240,575 | - | - | Common Stock | |
| Farah Champsi | Ten Percent Owner | 07 May 2014 | 4,551 | 4,551 | - | - | Common Stock | ||
| Farah Champsi | Ten Percent Owner | 07 May 2014 | 1,417,315 | 0 | - | - | Series D-2 Preferred Stock | ||
| Farah Champsi | Ten Percent Owner | 07 May 2014 | 3,033 | 3,381 | - | - | Common Stock | ||
| Farah Champsi | Ten Percent Owner | 07 May 2014 | 53,915 | 0 | - | - | Series D-2 Preferred Stock | ||
| Farah Champsi | Ten Percent Owner | 07 May 2014 | 3,033 | 0 | - | - | Common Stock Warrant (right to buy) | ||
| Farah Champsi | Ten Percent Owner | 07 May 2014 | 2,642 | 13,802 | - | - | Common Stock | ||
| Farah Champsi | Ten Percent Owner | 07 May 2014 | 20,975 | 0 | - | - | Series C Preferred Stock | ||
| Farah Champsi | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 07 May 2014 | 31,934 | 45,736 | - | - | Common Stock | |
| Farah Champsi | Ten Percent Owner | 07 May 2014 | 1,024,876 | 0 | - | - | Series D-1 Preferred Stock | ||
| Farah Champsi | Ten Percent Owner | 07 May 2014 | 174 | 348 | - | - | Common Stock | ||
| Farah Champsi | Ten Percent Owner | 07 May 2014 | 174 | 0 | - | - | Common Stock Warrant (right to buy) | ||
| Farah Champsi | Ten Percent Owner | 07 May 2014 | 1,848 | 11,160 | - | - | Common Stock | ||
| Farah Champsi | Ten Percent Owner | 07 May 2014 | 174 | 0 | - | - | Common Stock Warrant (right to buy) | ||
| Farah Champsi | Ten Percent Owner | 07 May 2014 | 5,931 | 9,312 | - | - | Common Stock | ||
| Pamela J Kirby | None | 07 May 2014 | 260,000 | 0 | - | - | Series D-2 Preferred Stock | ||
| Pamela J Kirby | None | 07 May 2014 | 12,745 | 12,745 | - | - | Common Stock | ||
| Pamela J Kirby | None | 07 May 2014 | 12,745 | 25,590 | - | - | Common Stock | ||
| Pamela J Kirby | None | 07 May 2014 | 12,745 | 0 | - | - | Common Stock Warrant (right to buy) | ||
| Patrick Langlois | None | 07 May 2014 | 5,251 | 26,785 | - | - | Common Stock | ||
| Patrick Langlois | None | 07 May 2014 | 107,142 | 0 | - | - | Series D-2 Preferred Stock | ||
| Patrick Langlois | None | 07 May 2014 | 5,251 | 0 | - | - | Common Stock Warrant (right to buy) | ||
| Patrick Langlois | None | 07 May 2014 | 5,252 | 10,503 | - | - | Common Stock | ||
| Yves J. Ribeill | Director, President and CEO | 07 May 2014 | 595 | 0 | - | - | Common Stock Warrant (right to buy) | ||
| Yves J. Ribeill | Director, President and CEO | 07 May 2014 | 12,142 | 0 | - | - | Series D-2 Preferred Stock | ||
| Yves J. Ribeill | Director, President and CEO | 07 May 2014 | 595 | 1,190 | - | - | Common Stock | ||
| Yves J. Ribeill | Director, President and CEO | 07 May 2014 | 595 | 595 | - | - | Common Stock | ||
| Laurent Arthaud | None | 07 May 2014 | 8,127 | 0 | - | - | Series D-1 Preferred Stock | ||
| Laurent Arthaud | None | 07 May 2014 | 34 | 3,806 | - | - | Common Stock | ||
| Laurent Arthaud | None | 07 May 2014 | 1,665 | 0 | - | - | Series D-2 Preferred Stock | ||
| Laurent Arthaud | None | 07 May 2014 | 81 | 4,507 | - | - | Common Stock | ||
| Laurent Arthaud | None | 07 May 2014 | 398 | 4,426 | - | - | Common Stock | ||
| Laurent Arthaud | None | 07 May 2014 | 34 | 3,772 | - | - | Common Stock | ||
| Laurent Arthaud | None | 07 May 2014 | 222 | 0 | - | - | Common Stock Warrant (right to buy) | ||
| Laurent Arthaud | None | 07 May 2014 | 222 | 4,028 | - | - | Common Stock | ||
| Laurent Arthaud | None | 07 May 2014 | 34 | 0 | - | - | Common Stock Warrant (right to buy) | ||
| Laurent Arthaud | None | 07 May 2014 | 34 | 0 | - | - | Common Stock Warrant (right to buy) | ||
| Jean-Yves Nothias | None | 07 May 2014 | 5,251 | 0 | - | - | Common Stock Warrant (right to buy) | ||
| Jean-Yves Nothias | None | 07 May 2014 | 166,482 | 0 | - | - | Series B Preferred Stock | ||
| Jean-Yves Nothias | None | 07 May 2014 | 313,996 | 0 | - | - | Series C Preferred Stock | ||
| Jean-Yves Nothias | None | 07 May 2014 | 42,336 | 214,495 | - | - | Common Stock | ||
| Jean-Yves Nothias | None | 07 May 2014 | 25,998 | 0 | - | - | Common Stock Warrant (right to buy) | ||
| Jean-Yves Nothias | None | 07 May 2014 | 863,672 | 0 | - | - | Series D-1 Preferred Stock | ||
| Jean-Yves Nothias | None | 07 May 2014 | 5,251 | 0 | - | - | Common Stock Warrant (right to buy) | ||
| Jean-Yves Nothias | None | 07 May 2014 | 46,863 | 83,363 | - | - | Common Stock | ||
| Jean-Yves Nothias | None | 07 May 2014 | 30,582 | 245,077 | - | - | Common Stock | ||
| Jean-Yves Nothias | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 07 May 2014 | 50,000 | 295,077 | - | - | Common Stock | |
| Jean-Yves Nothias | None | 07 May 2014 | 5,251 | 5,251 | - | - | Common Stock | ||
| Jean-Yves Nothias | None | 07 May 2014 | 88,796 | 172,159 | - | - | Common Stock | ||
| Jean-Yves Nothias | None | 07 May 2014 | 623,880 | 0 | - | - | Series D-2 Preferred Stock | ||
| Jean-Yves Nothias | None | 07 May 2014 | 5,251 | 10,502 | - | - | Common Stock | ||
| Jean-Yves Nothias | None | 07 May 2014 | 25,998 | 36,500 | - | - | Common Stock |